Novo Integrated Sciences extends CEO Mattacchione's resignation to April 30, 2025

Novo Integrated Sciences, Inc.

CEO Robert Mattacchione's resignation effective date extended from March 31 to no later than April 30, 2025.
Extension is to allow time for efficient transition of CEO position.
Mattacchione intends to remain Chairman of the Board and Chairman of subsidiary Novo Healthnet after CEO departure.
Resignation is not due to any disagreement with company operations, policies, or practices.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Robert Mattacchione

Chief Executive Officer

Novo Integrated Sciences, Inc.

Effective: 2025-04-30
Filed: April 4, 2025, 7:59 PM ET

thereafter, on March 31, 2025, the Company and Mr. Mattacchione agreed to extend the effective date of Mr. Mattacchione’s resignation to no later than April 30, 2025

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Robert Mattacchione resigned as Chief Executive Officer at Novo Integrated Sciences, Inc..

Action: resigned
Role: Chief Executive Officer

Exact text from the filing

thereafter, on March 31, 2025, the Company and Mr. Mattacchione agreed to extend the effective date of Mr. Mattacchione’s resignation to no later than April 30, 2025

View on SEC.gov

Source: SEC EDGAR

accession 0001641172-25-002779

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.